Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoquercetin for Sunitinib-Induced Fatigue in Kidney Cancer
NCT02446795Phase 2Unknown
- Sponsor
- Consorzio Oncotech
- Start
- Nov 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isoquercetin in fatigue, sponsored by Consorzio Oncotech. Status: unknown.
02
Drugs
isoquercetin
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT02446795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02446795.